ZimVie’s Q2 sales, Accelus’ implant milestone and more: 4 device company notes

Accelus reaches a milestone with a new implant and three more updates from spine devicemakers since Aug. 10:

Advertisement

1. ZimVie on Aug. 10 reported net sales of $233.4 million in the second quarter. Read more details here.

2. Max Reinhardt was elected to the board of directors at Sure Retractors, a medical device company specializing in spinal surgery.

3. Kalman Blumberg, MD, was first to use Accelus’ TiHawk11 interbody fusion system, and 150 devices have been implanted since.

4. Intraoperative neuromonitoring company Assure Holdings saw its second-quarter 2022 managed case volume jump by about 36 percent year over year. Read more here.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.